Capital Flow Monitor · Sponsors · CIK 2130826
HB-WIN 2026 Skillmaker Series - a series of HB-WIN LLC
107 KILMAYNE DRIVE, CARY, NC, 27511 · 9193356001
Pooled Investment Fund / Venture Capital Fund · Limited Liability Company· inc. DELAWARE true 2026
Fit score
—
Offering
$475K
Sold
$121K
% sold
25.5%
Investors
11
Min investment
$5K
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2026-04-21 | D ·current | 506(b) | $475K | $121K | 25.5% | 11 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.
-
John Michael Harlow — Director, Clayton, NC
12 other raises
- HB-WIN 2024 Lumata Series, a series of HB-WIN LLC $88K of $500K · 17.6%
- Harbright 2026 VQ Biomedical Series, a series of Harbright LLC $597K of $1.0M · 59.7%
- HB-WIN 2026 VQ Biomedical Series - a series of HB-WIN LLC $265K of $500K · 53.0%
- HB-WIN 2025 Invicta Water Series, a series of HB-WIN LLC $332K of $500K · 66.4%
- HB-WIN 2026 inSoma Series - a series of HB-WIN LLC $40K of $475K · 8.4%
- HB-WIN 2024 Deep Blue Series, a series of HB-WIN LLC $100K of —
- HB-WIN 2023 Voxel Series, a series of HB-WIN LLC $328K of $1.5M · 21.9%
- HB-WIN 2023 SonoVascular Series, a series of HB-WIN LLC $204K of $1.0M · 20.4%
- Harbright 2025 Materna Series, a series of Harbright LLC $25K of $3.0M · 0.8%
- Harbright 2024 SonoVascular Series, a series of Harbright LLC $60K of $1.5M · 4.0%
- HB-WIN 2025 Eventuall Series, a series of HB-WIN LLC $226K of $250K · 90.4%
- HB-WIN 2025 Ariso Series, a series of HB-WIN LLC $385K of $400K · 96.3%
-
Robert Earl Ross — Director / Promoter, Cary, NC
12 other raises
- HB-WIN 2024 Lumata Series, a series of HB-WIN LLC $88K of $500K · 17.6%
- Harbright 2026 VQ Biomedical Series, a series of Harbright LLC $597K of $1.0M · 59.7%
- HB-WIN 2026 VQ Biomedical Series - a series of HB-WIN LLC $265K of $500K · 53.0%
- HB-WIN 2025 Invicta Water Series, a series of HB-WIN LLC $332K of $500K · 66.4%
- HB-WIN 2026 inSoma Series - a series of HB-WIN LLC $40K of $475K · 8.4%
- HB-WIN 2024 Deep Blue Series, a series of HB-WIN LLC $100K of —
- HB-WIN 2023 Voxel Series, a series of HB-WIN LLC $328K of $1.5M · 21.9%
- HB-WIN 2023 SonoVascular Series, a series of HB-WIN LLC $204K of $1.0M · 20.4%
- Harbright 2025 Materna Series, a series of Harbright LLC $25K of $3.0M · 0.8%
- Harbright 2024 SonoVascular Series, a series of Harbright LLC $60K of $1.5M · 4.0%
- HB-WIN 2025 Eventuall Series, a series of HB-WIN LLC $226K of $250K · 90.4%
- HB-WIN 2025 Ariso Series, a series of HB-WIN LLC $385K of $400K · 96.3%
-
John Powell Leachman — Director / Promoter, Gainesville, GA
12 other raises
- HB-WIN 2024 Lumata Series, a series of HB-WIN LLC $88K of $500K · 17.6%
- Harbright 2026 VQ Biomedical Series, a series of Harbright LLC $597K of $1.0M · 59.7%
- HB-WIN 2026 VQ Biomedical Series - a series of HB-WIN LLC $265K of $500K · 53.0%
- HB-WIN 2025 Invicta Water Series, a series of HB-WIN LLC $332K of $500K · 66.4%
- HB-WIN 2026 inSoma Series - a series of HB-WIN LLC $40K of $475K · 8.4%
- HB-WIN 2024 Deep Blue Series, a series of HB-WIN LLC $100K of —
- HB-WIN 2023 Voxel Series, a series of HB-WIN LLC $328K of $1.5M · 21.9%
- HB-WIN 2023 SonoVascular Series, a series of HB-WIN LLC $204K of $1.0M · 20.4%
- Harbright 2025 Materna Series, a series of Harbright LLC $25K of $3.0M · 0.8%
- Harbright 2024 SonoVascular Series, a series of Harbright LLC $60K of $1.5M · 4.0%
- HB-WIN 2025 Eventuall Series, a series of HB-WIN LLC $226K of $250K · 90.4%
- HB-WIN 2025 Ariso Series, a series of HB-WIN LLC $385K of $400K · 96.3%
Placement agents
- No sales compensation reported — direct raise.
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.